CT SB00552

Authorizes prescribing practitioners to issue standing orders to pharmacists for dispensing FDA-approved opioid antagonists administered by intranasal or auto-injection delivery systems to persons at risk of opioid overdose or their family members and friends.

Allows certified pharmacists to dispense opioid antagonists pursuant to standing orders without violating any standard of care, provided they have completed training and certification approved by the Commissioner of Consumer Protection.

Permits certified pharmacists to prescribe opioid antagonists directly in good faith, with requirements to provide training on administration and maintain records of all dispensing and training activities.

Prohibits pharmacists from delegating or directing other persons to prescribe, dispense, or train others in the administration of opioid antagonists; only certified pharmacists may perform these functions.

Effective date of October 1, 2017; authorizes the Commissioner of Consumer Protection to adopt implementing regulations.